HK Stock MarketDetailed Quotes

02120 KN HOSPITAL

Watchlist

12.020
-0.040-0.33%

Not Open Jan 7 16:08 CST

873.49MMarket Cap8.58P/E (TTM)

KN HOSPITAL Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

Turnover

6.56%828.96M

7.50%1.6B

5.37%777.93M

14.45%1.48B

21.48%738.3M

31.18%1.3B

30.65%607.74M

14.91%989.01M

22.76%465.15M

15.38%860.69M

Operating income

6.56%828.96M

7.50%1.6B

5.37%777.93M

14.45%1.48B

21.48%738.3M

31.18%1.3B

30.65%607.74M

14.91%989.01M

22.76%465.15M

15.38%860.69M

Operating expenses

-4.58%-602.8M

-4.70%-1.19B

-6.63%-576.39M

-16.89%-1.13B

-19.02%-540.54M

-32.81%-968.43M

-34.81%-454.14M

-11.12%-729.17M

-17.42%-336.86M

-32.90%-656.18M

Gross profit

12.22%226.16M

16.49%411.14M

1.90%201.53M

7.27%352.93M

28.76%197.77M

26.62%329M

19.73%153.6M

27.06%259.84M

39.40%128.29M

-18.92%204.51M

Selling expenses

-18.15%-9.25M

-13.99%-17.1M

-28.00%-7.83M

-45.17%-15M

-24.85%-6.12M

-28.03%-10.34M

-32.50%-4.9M

-1.19%-8.07M

17.42%-3.7M

-55.15%-7.98M

Administrative expenses

-4.27%-106.27M

-3.47%-213.03M

-7.41%-101.92M

-16.73%-205.89M

-24.76%-94.89M

-37.39%-176.37M

-39.21%-76.06M

-4.08%-128.38M

-3.31%-54.64M

-25.85%-123.34M

Research and development expenses

-17.58%-17.59M

1.70%-32.47M

0.69%-14.96M

-18.12%-33.03M

-27.58%-15.06M

-33.33%-27.96M

-347.63%-11.81M

-248.49%-20.97M

-14.47%-2.64M

-4.97%-6.02M

Profit from asset sales

---74.99K

-83.24%68.09K

----

611.55%406.18K

--389.32K

-113.31%-79.4K

----

--596.7K

----

Revaluation surplus

---98.52K

101.34%214.41K

----

-269.66%-15.98M

-97.73%30.71K

42.70%9.42M

--1.35M

244.16%6.6M

----

--1.92M

-Changes in the fair value of other assets

---98.52K

101.34%214.41K

----

-269.66%-15.98M

-97.73%30.71K

42.70%9.42M

--1.35M

244.16%6.6M

----

--1.92M

Impairment and provision

-85.53%-5.58M

73.68%-9.35M

-10.19%-3.01M

-327.15%-35.54M

-18.09%-2.73M

2.07%-8.32M

85.64%-2.31M

70.96%-8.5M

-50.15%-16.11M

-24.39%-29.26M

-Other impairment is provision

-85.53%-5.58M

73.68%-9.35M

-10.19%-3.01M

-327.15%-35.54M

-18.09%-2.73M

2.07%-8.32M

85.64%-2.31M

70.96%-8.5M

-50.15%-16.11M

-24.39%-29.26M

Special items of operating profit

29.18%7.27M

-44.20%9.91M

0.02%5.63M

-13.62%17.76M

-47.55%5.63M

795.26%20.56M

137.32%10.73M

-93.39%2.3M

-84.99%4.52M

14,631.70%34.73M

Operating profit

15.18%88.29M

135.42%142.9M

-7.64%76.66M

-53.36%60.7M

21.43%83M

32.81%130.15M

27.24%68.35M

41.34%98M

5.56%53.72M

-38.61%69.34M

Financing cost

-21.36%-24.47M

6.45%-41.45M

6.88%-20.16M

-17.66%-44.31M

-25.59%-21.65M

-63.18%-37.66M

-45.51%-17.24M

1.75%-23.08M

-16.15%-11.85M

-227.53%-23.49M

Special items of earning before tax

-162.34%-2.31M

-188.42%-2.27M

87.44%3.71M

-124.60%-787.06K

-24.72%1.98M

628.67%3.2M

206.43%2.63M

-106.25%-605.17K

-120.64%-2.47M

748.65%9.68M

Earning before tax

2.17%61.51M

535.58%99.18M

-4.93%60.21M

-83.69%15.6M

17.84%63.33M

28.76%95.69M

36.39%53.74M

33.85%74.32M

-25.17%39.4M

-48.07%55.52M

Tax

-43.90%-16.52M

53.90%-12.25M

39.94%-11.48M

51.54%-26.57M

-9.16%-19.11M

-78.82%-54.83M

-66.68%-17.51M

-77.29%-30.66M

-47.51%-10.5M

45.85%-17.3M

After-tax profit from continuing operations

-7.66%45M

892.53%86.93M

10.20%48.73M

-126.84%-10.97M

22.03%44.22M

-6.40%40.86M

25.39%36.24M

14.20%43.66M

-36.54%28.9M

-49.01%38.23M

Earning after tax

-7.66%45M

892.53%86.93M

10.20%48.73M

-126.84%-10.97M

22.03%44.22M

-6.40%40.86M

25.39%36.24M

14.20%43.66M

-36.54%28.9M

-49.01%38.23M

Minority profit

-215.03%-5.73M

-92.58%983.8K

-8.35%4.98M

517.28%13.25M

339.93%5.43M

73.78%-3.18M

116.45%1.23M

36.45%-12.11M

-15.11%-7.51M

-238.79%-19.06M

Profit attributable to shareholders

15.94%50.72M

454.85%85.95M

12.79%43.75M

-155.00%-24.22M

10.81%38.79M

-21.04%44.04M

-3.86%35M

-2.65%55.77M

-30.07%36.41M

-28.92%57.29M

Basic earnings per share

15.25%0.68

459.38%1.15

13.46%0.59

-152.46%-0.32

8.33%0.52

-20.78%0.61

-4.00%0.48

-1.28%0.77

-29.58%0.5

-29.09%0.78

Diluted earnings per share

15.25%0.68

459.38%1.15

13.46%0.59

-154.24%-0.32

8.33%0.52

-21.33%0.59

-4.00%0.48

-2.60%0.75

-28.57%0.5

-29.36%0.77

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019
Turnover	6.56%828.96M	7.50%1.6B	5.37%777.93M	14.45%1.48B	21.48%738.3M	31.18%1.3B	30.65%607.74M	14.91%989.01M	22.76%465.15M	15.38%860.69M
Operating income	6.56%828.96M	7.50%1.6B	5.37%777.93M	14.45%1.48B	21.48%738.3M	31.18%1.3B	30.65%607.74M	14.91%989.01M	22.76%465.15M	15.38%860.69M
Operating expenses	-4.58%-602.8M	-4.70%-1.19B	-6.63%-576.39M	-16.89%-1.13B	-19.02%-540.54M	-32.81%-968.43M	-34.81%-454.14M	-11.12%-729.17M	-17.42%-336.86M	-32.90%-656.18M
Gross profit	12.22%226.16M	16.49%411.14M	1.90%201.53M	7.27%352.93M	28.76%197.77M	26.62%329M	19.73%153.6M	27.06%259.84M	39.40%128.29M	-18.92%204.51M
Selling expenses	-18.15%-9.25M	-13.99%-17.1M	-28.00%-7.83M	-45.17%-15M	-24.85%-6.12M	-28.03%-10.34M	-32.50%-4.9M	-1.19%-8.07M	17.42%-3.7M	-55.15%-7.98M
Administrative expenses	-4.27%-106.27M	-3.47%-213.03M	-7.41%-101.92M	-16.73%-205.89M	-24.76%-94.89M	-37.39%-176.37M	-39.21%-76.06M	-4.08%-128.38M	-3.31%-54.64M	-25.85%-123.34M
Research and development expenses	-17.58%-17.59M	1.70%-32.47M	0.69%-14.96M	-18.12%-33.03M	-27.58%-15.06M	-33.33%-27.96M	-347.63%-11.81M	-248.49%-20.97M	-14.47%-2.64M	-4.97%-6.02M
Profit from asset sales	---74.99K	-83.24%68.09K	----	611.55%406.18K	--389.32K	-113.31%-79.4K	----	--596.7K	----	----
Revaluation surplus	---98.52K	101.34%214.41K	----	-269.66%-15.98M	-97.73%30.71K	42.70%9.42M	--1.35M	244.16%6.6M	----	--1.92M
-Changes in the fair value of other assets	---98.52K	101.34%214.41K	----	-269.66%-15.98M	-97.73%30.71K	42.70%9.42M	--1.35M	244.16%6.6M	----	--1.92M
Impairment and provision	-85.53%-5.58M	73.68%-9.35M	-10.19%-3.01M	-327.15%-35.54M	-18.09%-2.73M	2.07%-8.32M	85.64%-2.31M	70.96%-8.5M	-50.15%-16.11M	-24.39%-29.26M
-Other impairment is provision	-85.53%-5.58M	73.68%-9.35M	-10.19%-3.01M	-327.15%-35.54M	-18.09%-2.73M	2.07%-8.32M	85.64%-2.31M	70.96%-8.5M	-50.15%-16.11M	-24.39%-29.26M
Special items of operating profit	29.18%7.27M	-44.20%9.91M	0.02%5.63M	-13.62%17.76M	-47.55%5.63M	795.26%20.56M	137.32%10.73M	-93.39%2.3M	-84.99%4.52M	14,631.70%34.73M
Operating profit	15.18%88.29M	135.42%142.9M	-7.64%76.66M	-53.36%60.7M	21.43%83M	32.81%130.15M	27.24%68.35M	41.34%98M	5.56%53.72M	-38.61%69.34M
Financing cost	-21.36%-24.47M	6.45%-41.45M	6.88%-20.16M	-17.66%-44.31M	-25.59%-21.65M	-63.18%-37.66M	-45.51%-17.24M	1.75%-23.08M	-16.15%-11.85M	-227.53%-23.49M
Special items of earning before tax	-162.34%-2.31M	-188.42%-2.27M	87.44%3.71M	-124.60%-787.06K	-24.72%1.98M	628.67%3.2M	206.43%2.63M	-106.25%-605.17K	-120.64%-2.47M	748.65%9.68M
Earning before tax	2.17%61.51M	535.58%99.18M	-4.93%60.21M	-83.69%15.6M	17.84%63.33M	28.76%95.69M	36.39%53.74M	33.85%74.32M	-25.17%39.4M	-48.07%55.52M
Tax	-43.90%-16.52M	53.90%-12.25M	39.94%-11.48M	51.54%-26.57M	-9.16%-19.11M	-78.82%-54.83M	-66.68%-17.51M	-77.29%-30.66M	-47.51%-10.5M	45.85%-17.3M
After-tax profit from continuing operations	-7.66%45M	892.53%86.93M	10.20%48.73M	-126.84%-10.97M	22.03%44.22M	-6.40%40.86M	25.39%36.24M	14.20%43.66M	-36.54%28.9M	-49.01%38.23M
Earning after tax	-7.66%45M	892.53%86.93M	10.20%48.73M	-126.84%-10.97M	22.03%44.22M	-6.40%40.86M	25.39%36.24M	14.20%43.66M	-36.54%28.9M	-49.01%38.23M
Minority profit	-215.03%-5.73M	-92.58%983.8K	-8.35%4.98M	517.28%13.25M	339.93%5.43M	73.78%-3.18M	116.45%1.23M	36.45%-12.11M	-15.11%-7.51M	-238.79%-19.06M
Profit attributable to shareholders	15.94%50.72M	454.85%85.95M	12.79%43.75M	-155.00%-24.22M	10.81%38.79M	-21.04%44.04M	-3.86%35M	-2.65%55.77M	-30.07%36.41M	-28.92%57.29M
Basic earnings per share	15.25%0.68	459.38%1.15	13.46%0.59	-152.46%-0.32	8.33%0.52	-20.78%0.61	-4.00%0.48	-1.28%0.77	-29.58%0.5	-29.09%0.78
Diluted earnings per share	15.25%0.68	459.38%1.15	13.46%0.59	-154.24%-0.32	8.33%0.52	-21.33%0.59	-4.00%0.48	-2.60%0.75	-28.57%0.5	-29.36%0.77
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Lixin Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)	--	PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)	--	PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks